Register entry
IRONWOOD PHARMACEUTICALS INC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 24
- Countries
- 0
Exclusivity
Patents and exclusivities
24| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10183012 | DUZALLO, ZURAMPICallopurinol; lesinurad; lesinurad | use | Nov 2028 |
| 8283369 | DUZALLO, ZURAMPICallopurinol; lesinurad; lesinurad | use | Nov 2028 |
| 8546437 | DUZALLO, ZURAMPICallopurinol; lesinurad; lesinurad | use | Apr 2029 |
| 8084483 | DUZALLO, ZURAMPICallopurinol; lesinurad; lesinurad | use | Aug 2029 |
| 8357713 | DUZALLO, ZURAMPICallopurinol; lesinurad; lesinurad | product | Dec 2029 |
| 9216179 | DUZALLO, ZURAMPICallopurinol; lesinurad; lesinurad | use | Aug 2031 |
| 9956205 | DUZALLO, ZURAMPICallopurinol; lesinurad; lesinurad | use | Dec 2031 |
| 8546436 | DUZALLO, ZURAMPICallopurinol; lesinurad; lesinurad | substance, product | Feb 2032 |
Enquiry
Common questions
- Is IRONWOOD PHARMACEUTICALS INC FDA approved?
- IRONWOOD PHARMACEUTICALS INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.